NFA
MACK

Nationwide Fund Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Nationwide Fund Advisors’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,138
Closed -$105K – 3055
2017
Q3 		$105K Sell
9,138
-1
-0% -$11 ﹤0.01% 2879
2017
Q2 		$89K Sell
9,139
-3,737
-29% -$76.3K ﹤0.01% 2949
2017
Q1 		$312K Sell
12,876
-1,408
-10% -$35.2K ﹤0.01% 2397
2016
Q4 		$459K Sell
14,284
-525
-4% -$22.4K ﹤0.01% 2213
2016
Q3 		$740K Sell
14,809
-508
-3% -$21.1K ﹤0.01% 1963
2016
Q2 		$650K Buy
15,317
+3,444
+29% +$188K ﹤0.01% 2000
2016
Q1 		$782K Buy
11,873
+58
+0.5% +$3.03K ﹤0.01% 1845
2015
Q4 		$734K Buy
11,815
+2,761
+30% +$194K ﹤0.01% 1893
2015
Q3 		$606K Hold
9,054
– – ﹤0.01% 1991
2015
Q2 		$881K Sell
9,054
-79
-0.9% -$7.52K ﹤0.01% 1933
2015
Q1 		$854K Sell
9,133
-366
-4% -$31.1K ﹤0.01% 1964
2014
Q4 		$845K Sell
9,499
-88
-0.9% -$6.41K ﹤0.01% 1898
2014
Q3 		$662K Sell
9,587
-43
-0.4% -$2.3K ﹤0.01% 2049
2014
Q2 		$552K Buy
9,630
+134
+1% +$6.8K ﹤0.01% 2209
2014
Q1 		$377K Hold
9,496
– – ﹤0.01% 2195
2013
Q4 		$399K Sell
9,496
-244
-3% -$7.07K ﹤0.01% 2345
2013
Q3 		$291K Buy
9,740
+5,179
+114% +$181K ﹤0.01% 2485
2013
Q2 		$242K Buy
+4,561
New +$200K ﹤0.01% 2397

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nationwide Fund Advisors's MACK Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2017, closing a stake of 9,138 shares — an estimated $105K sold.

Nationwide Fund Advisors first reported a position in MACK in Q2 2013 and held it in 18 quarters. The position peaked at $881K in Q2 2015. 78 funds tracked by Wall St. Rank hold MACK as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 9,138 Merrimack Pharmaceuticals, Inc. shares in Q4 2017, an estimated $105K.
  • Nationwide Fund Advisors first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Merrimack Pharmaceuticals, Inc. position peaked at $881K in Q2 2015.
  • 78 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.